𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cytogenetics of long-term survivors of ETV6-RUNX1 fusion positive acute lymphoblastic leukemia

✍ Scribed by Zoë J. Konn; Mary Martineau; Nicholas Bown; Sue Richards; John Swansbury; Polly Talley; Sarah L. Wright; Christine J. Harrison


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
198 KB
Volume
49
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

This study describes the cytogenetics of 33 children with ETV6‐RUNX1 positive acute lymphoblastic leukemia (ALL) who had been in continuous complete remission for a minimum of 8.8 years [median event‐free survival (EFS) 10.9 years]. The results were compared with a published series of 16 fusion positive patients treated on the same childhood ALL trial, who had relapsed (median EFS, 2.3 years). Interphase fluorescence in situ hybridization (FISH) at diagnosis showed deletion of the second ETV6 signal from all fusion positive cells in 45% of the long‐term survivors but in none of the relapsed patients, whereas patients with mixed populations with retained or lost second signals were more frequent among those who had relapsed (69%) than the long‐term survivors (21%). Interphase populations with two fusion signals in 18% of the long‐term survivors and 31% of relapsed patients were smaller in the long‐term survivors (median, 4% of total cells) than in the relapsed patients (median, 84%). The additional copy of chromosome 21 in 30% of long‐term survivors and in 69% of relapsed patients was a derived chromosome 21 in 20% and 55% of patients, respectively. Metaphase FISH for 26 long‐term survivors and 15 relapsed patients revealed complex karyotypes in both groups. Variant translocations involved different chromosome arms between the long‐term survivors and relapsed patients. It appears that the two groups have some distinguishing cytogenetic features at the time of diagnosis, which may provide pointers to relapse that are worthy of more detailed study. © 2009 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


The complex genomic profile of ETV6-RUNX
✍ Helen Parker; Qian An; Kerry Barber; Marian Case; Teresa Davies; Zoë Konn; Adam 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB

## Abstract The __ETV6‐RUNX1__ fusion is the molecular consequence of the t(12;21)(p13;q22) seen in ∼25% of children with acute lymphoblastic leukemia (ALL). Studies have shown that the fusion alone is insufficient for the initiation of leukemia; additional genetic changes are required. Genomic pro

Cytogenetic patterns in ETV6/RUNX1-posit
✍ Erik Forestier; Mette K. Andersen; Kirsi Autio; Elisabeth Blennow; Georg Borgstr 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

## Abstract Between 1992 and 2004, 1,140 children (1 to <15 years) were diagnosed with B‐cell precursor acute lymphoblastic leukemia (ALL) in the Nordic countries. Of these, 288 (25%) were positive for t(12;21)(p13;q22) [__ETV6/RUNX1__]. G‐banding analyses were successful in 245 (85%); 43 (15%) wer

Clonal variation of the immunogenotype i
✍ Martina Peham; Marianne Konrad; Jochen Harbott; Margit König; Oskar A Haas; E. R 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

## Abstract Recent data suggest that late relapses evolve from an ancestral __ETV6__/__RUNX1__‐positive (also designated __TEL__/__AML1__‐positive) clone resulting from secondary changes (__ETV6__ deletion) that differ from those of the initial leukemia and, as a consequence, may also deviate in th